We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$151M
AUM Growth
+$2.37M
Cap. Flow
-$4.74M
Cap. Flow %
-3.14%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
BRKR icon
Bruker
BRKR
+$10.5M
2
AKYA
Akoya BioSciences
AKYA
+$2.61M

Top Sells

Rank Stock Value
1
GH icon
Guardant Health
GH
+$10.8M
2
DHR icon
Danaher
DHR
+$4.98M
3
CTKB icon
Cytek Biosciences
CTKB
+$2.05M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
1
Natera
NTRA
$46.9B
$48.9M 32.36%
881,436
– –
ADPT icon
2
Adaptive Biotechnologies
ADPT
$4.07B
$26.8M 17.69%
3,030,434
– –
AKYA
3
DELISTED
Akoya BioSciences
AKYA
$17.2M 11.35%
2,097,785
+250,000
+14% +$2.61M
MXCT icon
4
MaxCyte
MXCT
$143M
$16M 10.56%
3,225,000
– –
GH icon
5
Guardant Health
GH
$21.9B
$11.5M 7.6%
490,445
-378,000
-44% -$10.8M
BRKR icon
6
Bruker
BRKR
$8.94B
$11.4M 7.56%
+145,100
New +$10.5M
CTKB icon
7
Cytek Biosciences
CTKB
$611M
$10.2M 6.74%
1,109,000
-191,000
-15% -$2.05M
SONX
8
DELISTED
Sonendo, Inc.
SONX
$9.29M 6.14%
4,643,461
– –
DHR icon
9
Danaher
DHR
$149B
– –
-21,150
Closed -$4.98M

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Blue Water Life Science Advisors held 9 positions worth $151M, up 1.6% from $149M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors withdrew a net $4.74M in Q1 2023, closing 1 position and reducing 2 holdings. Its most notable exit was Danaher, an estimated $4.98M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Blue Water Life Science Advisors opened a new position in Bruker worth $11.4M.

  • Blue Water Life Science Advisors's largest Q1 2023 buy was Bruker: 145,100 shares worth $11.4M.
  • Blue Water Life Science Advisors added most to Akoya BioSciences in Q1 2023, an estimated $2.61M increase.
  • Blue Water Life Science Advisors's biggest Q1 2023 reduction was Guardant Health, cutting an estimated $10.8M.
  • Blue Water Life Science Advisors fully exited Danaher in Q1 2023, selling an estimated $4.98M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $151M portfolio in Q1 2023.
  • Blue Water Life Science Advisors opened 1 new position and closed 1 in Q1 2023.
  • Blue Water Life Science Advisors's portfolio value rose 1.6% quarter-over-quarter to $151M.

Based on Blue Water Life Science Advisors's 13F filing for Q1 2023, filed 15 May 2023.